Thyroid Eye Disease (TED) Global Market Report 2025

Description

Thyroid eye disease (TED), also known as Graves' Orbitopathy, is an autoimmune disorder marked by inflammation and swelling of the tissues surrounding the eyes, often linked to thyroid conditions. TED can lead to symptoms such as bulging eyes, double vision, and eye discomfort.

The primary treatment approaches for TED include medical, surgical, and a combination of both. Medical management typically involves corticosteroids, immunosuppressive drugs, and biologic therapies to reduce inflammation, alleviate symptoms, and prevent disease progression. Treatment is customized based on disease severity, classified into mild, moderate, and severe stages. The drugs used belong to various categories, including biologics, small molecules, and others. They are administered through different routes, such as oral, intravenous, and subcutaneous methods, and are utilized by various end users, including hospitals, clinics, and other healthcare facilities.

The thyroid eye disease (TED) market research report is one of a series of new reports from The Business Research Company that provides thyroid eye disease (TED) market statistics, including the thyroid eye disease (TED) industry global market size, regional shares, competitors with the thyroid eye disease (TED) market share, detailed thyroid eye disease (TED) market segments, market trends, and opportunities, and any further data you may need to thrive in the thyroid eye disease (TED) industry. This thyroid eye disease (TED) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The thyroid eye disease (TED) market size has grown strongly in recent years. It will grow from $2.15 billion in 2024 to $2.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to the rising incidence of thyroid disorders, a growing emphasis on patient-centered care, increasing demand for cosmetic procedures, a higher prevalence of the disease, and the expansion of treatment options for TED.

The thyroid eye disease (TED) market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth during the forecast period can be driven by the rising prevalence of Graves' disease, increased funding across various industries, growing healthcare expenditure, greater use of thyroid hormone replacement therapy, and a higher incidence of thyroid disease. Key trends in this period include technological advancements, expanding R&D activities, the development of novel drugs, improvements in treatment options, and the introduction of new surgical techniques.

The increasing prevalence of thyroid disorders is expected to drive the expansion of the thyroid eye disease (TED) market. Thyroid disorders are medical conditions that disrupt the function of the thyroid gland, leading to hormonal imbalances and conditions such as hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. The rising incidence of thyroid disorders is attributed to factors such as increased iodine intake, autoimmune diseases, genetic predisposition, and improved awareness leading to higher diagnostic rates. Thyroid Eye Disease (TED) plays a significant role in the growing number of thyroid disorder cases, as it is a serious and common complication of Graves' disease, contributing to the overall burden and awareness of thyroid-related conditions. For example, in May 2024, the Canadian Cancer Society, a Canada-based non-profit organization, reported that an estimated 6,600 new cases of thyroid cancer are expected to be diagnosed in Canada in 2024, with approximately 280 projected fatalities. As a result, the increasing prevalence of thyroid disorders is fueling the growth of the thyroid eye disease (TED) market.

Leading companies in the thyroid eye disease (TED) market are prioritizing the development of innovative treatments, such as monoclonal antibody therapies, to provide more effective, targeted solutions that reduce inflammation, improve proptosis, and enhance overall patient outcomes. Monoclonal antibody therapies involve laboratory-engineered antibodies designed to mimic the immune system's ability to recognize and neutralize specific pathogens or abnormal cells. For instance, in September 2024, Amgen Inc., a US-based biotechnology company, announced that Japan's Ministry of Health, Labour and Welfare (MHLW) had approved TEPEZZA (teprotumumab) for the treatment of active thyroid eye disease (TED), a rare and potentially vision-threatening autoimmune disorder. TEPEZZA is the first and only FDA-approved therapy specifically for TED, offering a targeted treatment that helps reduce inflammation, swelling, and other debilitating symptoms associated with the disease. This approval is particularly significant for patients in Japan, as it introduces an effective new option for managing TED, a progressive condition that can cause severe eye bulging, vision impairment, and eye pain.

In October 2023, Amgen Inc., a US-based biopharmaceutical company, acquired Horizon Therapeutics plc for an undisclosed amount. This acquisition strengthens Amgen's rare and inflammatory disease portfolio by integrating Horizon's key therapies, expanding its global reach, and driving innovation for long-term growth. Horizon Therapeutics plc, an Ireland-based company, specializes in treatments for rare autoimmune and inflammatory diseases.

Major players in the thyroid eye disease (ted) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in thyroid eye disease (TED) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the thyroid eye disease (TED) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thyroid eye disease (TED) market includes revenues earned by entities by providing services such as diagnosis services, pharmaceutical services, surgical services, support, and counseling services and related products including thyroid hormone replacement therapy, immunosuppressive drugs, surgical products, and devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Thyroid Eye Disease (TED) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on thyroid eye disease (ted) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for thyroid eye disease (ted) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The thyroid eye disease (ted) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Type: Medical; Surgical; Combination Of Medical And Surgical
2) By Disease Severity: Mild; Moderate; Severe
3) By Drug Type: Biologics; Small Molecules; Others Drug Type
4) By Route Of Administration: Oral; Intravenous; Subcutaneous
5) By End User: Hospitals; Clinics; Other End Users
Subsegments:
1) By Medical: Corticosteroids; Teprotumumab; Antithyroid Medications; Other Medical Treatments
2) By Surgical: Orbital Decompression Surgery; Eyelid Surgery; Strabismus Surgery
3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression; Combination of Teprotumumab and Eyelid Surgery; Other Combined Approaches
Companies Mentioned: Hoffmann-La Roche AG; Amgen Inc.; Genentech Inc.; Horizon Therapeutics plc; Pierre Fabre S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34166

1. Executive Summary

2. Thyroid Eye Disease (TED) Market Characteristics

3. Thyroid Eye Disease (TED) Market Trends And Strategies

4. Thyroid Eye Disease (TED) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Thyroid Eye Disease (TED) Growth Analysis And Strategic Analysis Framework

5.1. Global Thyroid Eye Disease (TED) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Thyroid Eye Disease (TED) Market Growth Rate Analysis
5.4. Global Thyroid Eye Disease (TED) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Thyroid Eye Disease (TED) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Thyroid Eye Disease (TED) Total Addressable Market (TAM)

6. Thyroid Eye Disease (TED) Market Segmentation

6.1. Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical
Surgical
Combination Of Medical And Surgical
6.2. Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild
Moderate
Severe
6.3. Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics
Small Molecules
Others Drug Type
6.4. Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Subcutaneous
6.5. Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other End Users
6.6. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Teprotumumab
Antithyroid Medications
Other Medical Treatments
6.7. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Orbital Decompression Surgery
Eyelid Surgery
Strabismus Surgery
6.8. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical And Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Combination Of Corticosteroids And Orbital Decompression
Combination Of Teprotumumab And Eyelid Surgery
Other Combined Approaches

7. Thyroid Eye Disease (TED) Market Regional And Country Analysis

7.1. Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Thyroid Eye Disease (TED) Market

8.1. Asia-Pacific Thyroid Eye Disease (TED) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Thyroid Eye Disease (TED) Market

9.1. China Thyroid Eye Disease (TED) Market Overview
9.2. China Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Thyroid Eye Disease (TED) Market

10.1. India Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Thyroid Eye Disease (TED) Market

11.1. Japan Thyroid Eye Disease (TED) Market Overview
11.2. Japan Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Thyroid Eye Disease (TED) Market

12.1. Australia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Thyroid Eye Disease (TED) Market

13.1. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Thyroid Eye Disease (TED) Market

14.1. South Korea Thyroid Eye Disease (TED) Market Overview
14.2. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Thyroid Eye Disease (TED) Market

15.1. Western Europe Thyroid Eye Disease (TED) Market Overview
15.2. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Thyroid Eye Disease (TED) Market

16.1. UK Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Thyroid Eye Disease (TED) Market

17.1. Germany Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Thyroid Eye Disease (TED) Market

18.1. France Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Thyroid Eye Disease (TED) Market

19.1. Italy Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Thyroid Eye Disease (TED) Market

20.1. Spain Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Thyroid Eye Disease (TED) Market

21.1. Eastern Europe Thyroid Eye Disease (TED) Market Overview
21.2. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Thyroid Eye Disease (TED) Market

22.1. Russia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Thyroid Eye Disease (TED) Market

23.1. North America Thyroid Eye Disease (TED) Market Overview
23.2. North America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Thyroid Eye Disease (TED) Market

24.1. USA Thyroid Eye Disease (TED) Market Overview
24.2. USA Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Thyroid Eye Disease (TED) Market

25.1. Canada Thyroid Eye Disease (TED) Market Overview
25.2. Canada Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Thyroid Eye Disease (TED) Market

26.1. South America Thyroid Eye Disease (TED) Market Overview
26.2. South America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Thyroid Eye Disease (TED) Market

27.1. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Thyroid Eye Disease (TED) Market

28.1. Middle East Thyroid Eye Disease (TED) Market Overview
28.2. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Thyroid Eye Disease (TED) Market

29.1. Africa Thyroid Eye Disease (TED) Market Overview
29.2. Africa Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Thyroid Eye Disease (TED) Market Competitive Landscape And Company Profiles

30.1. Thyroid Eye Disease (TED) Market Competitive Landscape
30.2. Thyroid Eye Disease (TED) Market Company Profiles
- 30.2.1. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Horizon Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Pierre Fabre S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Thyroid Eye Disease (TED) Market Other Major And Innovative Companies

31.1. Innovent Biologics Inc.
31.2. ACELYRIN Inc.
31.3. Soleo Health
31.4. Zai Lab Limited
31.5. HanAll Biopharma Co. Ltd.
31.6. Tourmaline Bio Inc.
31.7. Zenas BioPharma Inc.
31.8. Immunovant Inc.
31.9. Verana Health
31.10. Harbour BioMed (Guangzhou) Co. Ltd.
31.11. Sling Therapeutics Inc.
31.12. Crinetics Pharmaceuticals Inc.
31.13. Lassen Therapeutics Inc.
31.14. Viridian Therapeutics Inc.
31.15. Minghui Pharmaceutical Inc.

32. Global Thyroid Eye Disease (TED) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Thyroid Eye Disease (TED) Market

34. Recent Developments In The Thyroid Eye Disease (TED) Market

35. Thyroid Eye Disease (TED) Market High Potential Countries, Segments and Strategies

35.1 Thyroid Eye Disease (TED) Market In 2029 - Countries Offering Most New Opportunities
35.2 Thyroid Eye Disease (TED) Market In 2029 - Segments Offering Most New Opportunities
35.3 Thyroid Eye Disease (TED) Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer